NO20004679L - Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelse - Google Patents
Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelseInfo
- Publication number
- NO20004679L NO20004679L NO20004679A NO20004679A NO20004679L NO 20004679 L NO20004679 L NO 20004679L NO 20004679 A NO20004679 A NO 20004679A NO 20004679 A NO20004679 A NO 20004679A NO 20004679 L NO20004679 L NO 20004679L
- Authority
- NO
- Norway
- Prior art keywords
- therapy
- pharmaceutical composition
- carbon atoms
- prevention
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7228098 | 1998-03-20 | ||
| PCT/JP1999/001335 WO1999048522A1 (en) | 1998-03-20 | 1999-03-17 | Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20004679D0 NO20004679D0 (no) | 2000-09-19 |
| NO20004679L true NO20004679L (no) | 2000-10-26 |
Family
ID=13484725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004679A NO20004679L (no) | 1998-03-20 | 2000-09-19 | Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelse |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6342531B1 (de) |
| EP (1) | EP1064021B1 (de) |
| JP (1) | JP2002507579A (de) |
| KR (1) | KR20010041967A (de) |
| CN (1) | CN1301173A (de) |
| AR (1) | AR018784A1 (de) |
| AT (1) | ATE275420T1 (de) |
| AU (1) | AU2852699A (de) |
| BR (1) | BR9908948A (de) |
| CA (1) | CA2324566A1 (de) |
| DE (1) | DE69919995T2 (de) |
| ES (1) | ES2224613T3 (de) |
| HU (1) | HUP0101428A2 (de) |
| ID (1) | ID27507A (de) |
| MX (1) | MXPA00009188A (de) |
| MY (1) | MY133063A (de) |
| NO (1) | NO20004679L (de) |
| PL (1) | PL342970A1 (de) |
| WO (1) | WO1999048522A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7766300A (en) * | 1999-10-07 | 2001-05-10 | Novaneuron Inc. | Gene necessary for striatal function, uses thereof, and compounds for modulatingsame |
| AU2001292287A1 (en) | 2000-10-26 | 2002-05-06 | Senju Pharmaceutical Co. Ltd. | Drug composition comprising dipeptydyl aldehyde derivative |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0564552A1 (de) | 1990-12-28 | 1993-10-13 | Cortex Pharmaceuticals, Inc. | Verwendung von calpaininhibitoren zur hemmung und behandlung von neurodegeneration |
| DE69628050T2 (de) | 1995-10-25 | 2004-04-01 | Senju Pharmaceutical Co., Ltd. | Angiogenese Hemmer |
-
1999
- 1999-03-17 EP EP99909212A patent/EP1064021B1/de not_active Expired - Lifetime
- 1999-03-17 CA CA002324566A patent/CA2324566A1/en not_active Abandoned
- 1999-03-17 JP JP2000537569A patent/JP2002507579A/ja not_active Ceased
- 1999-03-17 CN CN99806167A patent/CN1301173A/zh active Pending
- 1999-03-17 ES ES99909212T patent/ES2224613T3/es not_active Expired - Lifetime
- 1999-03-17 DE DE69919995T patent/DE69919995T2/de not_active Expired - Lifetime
- 1999-03-17 AT AT99909212T patent/ATE275420T1/de not_active IP Right Cessation
- 1999-03-17 MX MXPA00009188A patent/MXPA00009188A/es unknown
- 1999-03-17 MY MYPI99000998A patent/MY133063A/en unknown
- 1999-03-17 HU HU0101428A patent/HUP0101428A2/hu unknown
- 1999-03-17 PL PL99342970A patent/PL342970A1/xx not_active Application Discontinuation
- 1999-03-17 AU AU28526/99A patent/AU2852699A/en not_active Abandoned
- 1999-03-17 BR BR9908948-3A patent/BR9908948A/pt not_active Application Discontinuation
- 1999-03-17 KR KR1020007010291A patent/KR20010041967A/ko not_active Application Discontinuation
- 1999-03-17 US US09/646,529 patent/US6342531B1/en not_active Expired - Fee Related
- 1999-03-17 WO PCT/JP1999/001335 patent/WO1999048522A1/en active IP Right Grant
- 1999-03-17 ID IDW20002104A patent/ID27507A/id unknown
- 1999-03-19 AR ARP990101215A patent/AR018784A1/es unknown
-
2000
- 2000-09-19 NO NO20004679A patent/NO20004679L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999048522A1 (en) | 1999-09-30 |
| DE69919995T2 (de) | 2005-09-22 |
| ATE275420T1 (de) | 2004-09-15 |
| ES2224613T3 (es) | 2005-03-01 |
| DE69919995D1 (de) | 2004-10-14 |
| MY133063A (en) | 2007-10-31 |
| EP1064021A1 (de) | 2001-01-03 |
| CN1301173A (zh) | 2001-06-27 |
| KR20010041967A (ko) | 2001-05-25 |
| PL342970A1 (en) | 2001-07-16 |
| CA2324566A1 (en) | 1999-09-30 |
| BR9908948A (pt) | 2000-11-21 |
| JP2002507579A (ja) | 2002-03-12 |
| ID27507A (id) | 2001-04-12 |
| NO20004679D0 (no) | 2000-09-19 |
| HUP0101428A2 (hu) | 2001-09-28 |
| US6342531B1 (en) | 2002-01-29 |
| AU2852699A (en) | 1999-10-18 |
| MXPA00009188A (es) | 2002-04-24 |
| EP1064021B1 (de) | 2004-09-08 |
| AR018784A1 (es) | 2001-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9500240D0 (en) | New prolin-amide derivatives and pharmaceutical compositions containing them as active component | |
| JO2646B1 (en) | New differentiated cyclic compounds as beta - lactam inhibitors | |
| MY107740A (en) | Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof | |
| NO944911L (no) | Ikke-peptid-takykininreseptorantagonister | |
| EP1396493A4 (de) | Heterocyclische verbindungen | |
| EA200101077A1 (ru) | Композиция для профилактики или лечения слабоумия, включающая производное гидроксикоричной кислоты или экстракт растения рода angelicae, содержащий его | |
| HUP0100732A2 (hu) | Amidvegyületet és azolszármazékot tartalmazó szinergetikus hatású fungicid kompozíció és alkalmazása | |
| MXPA02002452A (es) | Agentes preventivos y terapeuticos para enfermedades de oftalmicas. | |
| NO160297C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oksoazetidinderivater | |
| IL148875A0 (en) | Sulfonyl hydrazide derivatives, their preparation and pharmaceutical compositions containing them | |
| EP0921122A4 (de) | Neue epoxysuccinamid-derivate oder ihre salze | |
| NO20004405L (no) | Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati | |
| DE69828197D1 (de) | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut | |
| AU695907B2 (en) | Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases | |
| NZ517315A (en) | New derivatives of A-500359 | |
| NO20004679L (no) | Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelse | |
| HUP0203118A2 (hu) | Béta-diszubsztituált metalloproteáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| DK0651743T3 (da) | Indolinyl-N-hydroxyurinstof- og N-hydroxamsyrederivater som lipoxygenaseinhibitorer | |
| SE9701396D0 (sv) | Compounds | |
| CA2377230A1 (en) | Benzimidazole compounds and medicaments comprising the same | |
| MXPA02012072A (es) | Derivados de 4,5-dihidro-tiazol-2-ilamina y su uso como inhibidores de no-sintasa. | |
| NO944476L (no) | Tetrahydro - og perhydro-isokinolinderivater og terapeutiske midler inneholdende dem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |